HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET ANALYSIS

High Potency Active Pharmaceutical Ingredients Market, By Molecule Type (Innovative and Generic), By Production Technology (Chemical Synthesis and Biotechnology), By Application (Oncology, Hormonal, Glaucoma and Others), By Geography (North America, Europe, Asia Pacific, Latin America, Middle East and Africa)

Published In : Jan 2024
Code : CMI1336
Pages :150
Formats :
Excel and PDF
Industry : Pharmaceutical

Leading Companies

Companies covered:

Lonza, Novartis International AG, BASF AG, SEQENS, Carbogen Amcis AG, Eli Lilly and Company, Teva Pharmaceutical Industries Ltd, Bristol-Myers Squibb, Pfizer Inc., Roche Diagnostics, Boehringer Ingelheim, Merck & Co, Bayer AG, Ajinomoto Bio-Pharma Services, Cambrex Corporation, Minakem, and Sanofi Aventis.

Top Companies in the Global High Potency Active Pharmaceutical Ingredients Market

- Lonza
- Novartis International AG
- BASF AG
- SEQENS
- Carbogen Amcis AG
- Eli Lilly and Company
- Teva Pharmaceutical Industries Ltd
- Bristol-Myers Squibb
- Pfizer Inc.
- Roche Diagnostics
- Boehringer Ingelheim
- Merck & Co
- Bayer AG
- Ajinomoto Bio-Pharma Services
- Cambrex Corporation
- Minakem
- Sanofi Aventis